1. This vaccine is specific to the Zaire strain. Assuming real world data demonstrate effectiveness, what is the outlook for vaccinating against other strains?
2. Can you address the politics of vaccine development and access? Apparently, Merck has discontinued vaccine development (and not sharing with GAVI?). Would we be correct in assuming this would not be the case if any Ebola outbreak had occurred in the US or Canada? What countries are contributing to and supporting vaccine development.
3. We should be able to prevent significant transmission of Ebola in the US, given Standard Precautions. What would we need to have in place in hospitals and health departments should a case or more of Ebola occur in the US (i.e., before a case, as in preparation)?
Should we all get the Ebola vaccine even if we aren’t planning to travel outside of the US?
1. This vaccine is specific to the Zaire strain. Assuming real world data demonstrate effectiveness, what is the outlook for vaccinating against other strains?
2. Can you address the politics of vaccine development and access? Apparently, Merck has discontinued vaccine development (and not sharing with GAVI?). Would we be correct in assuming this would not be the case if any Ebola outbreak had occurred in the US or Canada? What countries are contributing to and supporting vaccine development.
3. We should be able to prevent significant transmission of Ebola in the US, given Standard Precautions. What would we need to have in place in hospitals and health departments should a case or more of Ebola occur in the US (i.e., before a case, as in preparation)?